We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
What's new
This page lists items that we have published for the first time or updated in the last 7, 30 or 60 days. Use the filters to narrow results by audience, product type, content type or topic.
You can also stay informed by:
- subscribing to our updates to receive same-day notification emails on safety information, scheduling updates or media releases.
- checking our consultation hub.
- joining any upcoming events.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (8)
- Clinical trials (2)
- Committees and advisory bodies (1)
- Compliance and enforcement (9)
- Cosmetics (1)
- Fees and payments (1)
- Import and export (2)
- Labelling and packaging (4)
- Legislation (3)
- Manufacturing (6)
- Medicinal cannabis hub (1)
- Safety monitoring and information (8)
- Scheduling (national classification system) (4)
- Sunscreens (1)
- Unique Device Identification (UDI) hub (5)
- Vaping hub (1)
What's new
74 result(s) found, displaying 1 to 25
-
ConsultationWe are seeking feedback on whether 11 international scientific guidelines should be adopted.
-
ConsultationWe are seeking feedback on proposed changes to the Required Advisory Statements for Medicine Labels (RASML).
-
ConsultationWe are seeking feedback on proposed changes to improve the Therapeutic Goods Advertising Code.
-
ConsultationWe are seeking feedback on the regulation of radiopharmaceuticals in Australia. These medicines contain small amounts of radioactive material, used to support the diagnosis and treatment of serious conditions, including cancer and cardiovascular disease.
-
ConsultationWe are seeking public comment on issues and proposed amendments to the Permissible Indications Determination.
-
DatasetSearch approvals to import and supply medicines not in the Australian Register of Therapeutic Goods (ARTG) to address medicine shortages.
-
PageRead the latest enhancements and fixes to the Australian UDI Database.
-
PageHow to report a side effect, reaction or other problem with a therapeutic good. Your report can help keep others safe.
-
PageLearn how to add sponsor information to UDI records using the Australian UDI sponsor link template.
-
DatasetSearch our database of sponsor-requested cancellations from the ARTG.
-
PageThe TGA has a streamlined Consent to Supply process for Unique Device Identification related Essential Principles.
-
PageRead about court actions. It is our practice to publish details of regulatory compliance decisions and actions on our website.
-
PageThe Freedom of Information disclosure log gives access to information we've released in response to an FOI request.
-
PageLearn about GCP inspections of clinical trial sites of investigational biologicals, medicines and medical devices.
-
Media releasesWe have commenced proceedings in the Federal Court of Australia against Better Leaf Pty Ltd (Better Leaf), Better Life Aussie Pty Ltd (Better Life), and their sole director for the alleged unlawful advertising of medicinal cannabis.
-
GuidanceGuidance for sponsors of medical devices seeking to include a medical device (including in vitro diagnostic devices) in the Australian Register of Therapeutic Goods.
-
-
PageRead the latest enhancements and fixes to the Australian UDI Database Pre-Production environment.
-
TransactionIf you can’t find the information you need in our guidance, make an enquiry through our online portal.
-
TransactionReport non-compliant advertisement for a medicine, medical device or any other type of therapeutic good, using our online portal.
-
PageLearn how to electronically submit UDI records using GS1’s National Product Catalogue (NPC).
-
PageForms are used by sponsors, agents and manufacturers to apply for access to TGA Business Services.
-
PageApply for access and manage your account details.
-
Safety updatesWe are reviewing new information that has raised concerns regarding the integrity and reliability of the clinical trial data that supported the approval of TAVNEOS (avacopan) in Australia.
-
Scheduling decisions (final)This web publication constitutes a notice for amendments to the current Poisons Standard made under section 52D(2) of the Therapeutic Goods Act 1989